×

Select Your Country

English
Best Oncology Specialist In Delhi

Dr. Peush Bajpai

HOD & Consultant - Medical Hemato Oncologist

Delhi

Qualification

MBBS MD General Medicine Specialist Accreditation in Medical Oncology- European Society of Oncology (ESMO) Certification DM (Medical Oncology) Cancer Institute, Adyar, Chennai

Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • ASCO
  • NCR oncology group
  • ISMPO
  • ICON
  • Dwarka IMA
  • SIOP

Field of Expertise

  • Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma
  • Gynaecological Malignancies - Carcinoma Ovary, the endometrium
  • Haematological Malignancies - Multiple Myeloma, CML, CLL, and Autologous Bone marrow transplant
  • Soft-tissue Sarcomas and Osteosarcoma
  • Thoracic Malignancies - Lung Carcinoma
  • Immunotherapy
  • Precision Oncology

Languages Spoken

  • English
  • Hindi
  • Tamil

Talks & Publications

  • Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck malignancy http://medej.tnmgrmu.ac.in 2 (2).
  • Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
  • Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al.
  • Novel formulations of docetaxel, paclitaxel, and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al.
  • Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce a Durable Response Peush Bajpai et al. Journal of Gastrointestinal Cancer volume 50, pages943–946 (2019).
  • Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al.
  • Submitted for Publication: Collusion: The façade and its implications on Total pain management in palliative care -IJPC_81_20 (Indian Journal of palliative care Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai.
  • Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141 patients, ICON 2009 Chennai.
  • Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid Leukemia – Chronic Phase treated with Imatinib mesylate AND possible correlation with electrolyte imbalances. Asia-Pacific Hematology consortium held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21.
  • A multicenter, open-label, single-arm, phase IV study of Trastuzumab Emtansine in Indian patients with HER2 positive unresectable locally advanced or metastatic breast cancer who have received prior treatment with trastuzumab and a taxane.
  • A multi-center, observational, data collection registry study to monitor the routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY INTAS PHARMACEUTICALS LTD) in Indian patients.
  • A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma.
  • Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient).
  • Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
  • Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018.
  • Co-Organizer of Best Of SABCS 2018 April 2018.
  • Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice (GCP) on 1st March 2019.
  • CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019.
  • Dr. Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA. Click Here
  • Dr. Peush Bajpai explains about how early diagnosis and detection can identify Breast Cancer symptoms and treat it successfully on TV9 Bharatvarsh (Digital) | FB Live Session. Click Here
  • Dr. Peush Bajpai in an authored article on Watch out, lumps are not the only symptom of breast cancer observing Breast Cancer Awareness Month in Times Now News. Click Here
  • Dr. Peush Bajpai in an exclusive story on Oncologist answers FAQs on the ideal routine for cancer treatment in Times Now| World Cancer Day. Click Here
  • Dr. Peush Bajpai on Cancer and Precision Medicine in a live webinar on Business World.Click Here
  • Dr. Peush Bajpai on Cancer Treatment: Can I Have Chemotherapy During Pregnancy? in The Healthsite (Zee Digital) | Exclusive story.Click Here
  • Dr. Peush Bajpai on Doctor Explains: Menace of cancer in India| The Financial Express | World Cancer Day. Click Here
  • Dr. Peush Bajpai said in an exclusive Story, "Nearly 50-60 per cent cancers are due to poor lifestyle" to Financial Express. Click Here
  • SM Post | NDTV. Click Here

Awards & Achievements

  • First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass.
  • First prize in the All India Quiz at the Lymphoma leukemia meet in Mumbai organized by the European Society of Medical Oncology.
  • Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances.

Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • ASCO
  • NCR oncology group
  • ISMPO
  • ICON
  • Dwarka IMA
  • SIOP

Field of Expertise

  • Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma
  • Gynaecological Malignancies - Carcinoma Ovary, the endometrium
  • Haematological Malignancies - Multiple Myeloma, CML, CLL, and Autologous Bone marrow transplant
  • Soft-tissue Sarcomas and Osteosarcoma
  • Thoracic Malignancies - Lung Carcinoma
  • Immunotherapy
  • Precision Oncology

Languages Spoken

  • English
  • Hindi
  • Tamil

Talks & Publications

  • Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck malignancy http://medej.tnmgrmu.ac.in 2 (2).
  • Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
  • Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al.
  • Novel formulations of docetaxel, paclitaxel, and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al.
  • Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce a Durable Response Peush Bajpai et al. Journal of Gastrointestinal Cancer volume 50, pages943–946 (2019).
  • Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al.
  • Submitted for Publication: Collusion: The façade and its implications on Total pain management in palliative care -IJPC_81_20 (Indian Journal of palliative care Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai.
  • Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141 patients, ICON 2009 Chennai.
  • Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid Leukemia – Chronic Phase treated with Imatinib mesylate AND possible correlation with electrolyte imbalances. Asia-Pacific Hematology consortium held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21.
  • A multicenter, open-label, single-arm, phase IV study of Trastuzumab Emtansine in Indian patients with HER2 positive unresectable locally advanced or metastatic breast cancer who have received prior treatment with trastuzumab and a taxane.
  • A multi-center, observational, data collection registry study to monitor the routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY INTAS PHARMACEUTICALS LTD) in Indian patients.
  • A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma.
  • Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient).
  • Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
  • Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018.
  • Co-Organizer of Best Of SABCS 2018 April 2018.
  • Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice (GCP) on 1st March 2019.
  • CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019.
  • Dr. Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA. Click Here
  • Dr. Peush Bajpai explains about how early diagnosis and detection can identify Breast Cancer symptoms and treat it successfully on TV9 Bharatvarsh (Digital) | FB Live Session. Click Here
  • Dr. Peush Bajpai in an authored article on Watch out, lumps are not the only symptom of breast cancer observing Breast Cancer Awareness Month in Times Now News. Click Here
  • Dr. Peush Bajpai in an exclusive story on Oncologist answers FAQs on the ideal routine for cancer treatment in Times Now| World Cancer Day. Click Here
  • Dr. Peush Bajpai on Cancer and Precision Medicine in a live webinar on Business World.Click Here
  • Dr. Peush Bajpai on Cancer Treatment: Can I Have Chemotherapy During Pregnancy? in The Healthsite (Zee Digital) | Exclusive story.Click Here
  • Dr. Peush Bajpai on Doctor Explains: Menace of cancer in India| The Financial Express | World Cancer Day. Click Here
  • Dr. Peush Bajpai said in an exclusive Story, "Nearly 50-60 per cent cancers are due to poor lifestyle" to Financial Express. Click Here
  • SM Post | NDTV. Click Here

Awards & Achievements

  • First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass.
  • First prize in the All India Quiz at the Lymphoma leukemia meet in Mumbai organized by the European Society of Medical Oncology.
  • Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances.

Field of Expertise

  • Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma
  • Gynaecological Malignancies - Carcinoma Ovary, the endometrium
  • Haematological Malignancies - Multiple Myeloma, CML, CLL, and Autologous Bone marrow transplant
  • Soft-tissue Sarcomas and Osteosarcoma
  • Thoracic Malignancies - Lung Carcinoma
  • Immunotherapy
  • Precision Oncology

Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • ASCO
  • NCR oncology group
  • ISMPO
  • ICON
  • Dwarka IMA
  • SIOP

Languages Spoken

  • English
  • Hindi
  • Tamil

Talks & Publications

  • Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck malignancy http://medej.tnmgrmu.ac.in 2 (2).
  • Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
  • Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al.
  • Novel formulations of docetaxel, paclitaxel, and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al.
  • Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce a Durable Response Peush Bajpai et al. Journal of Gastrointestinal Cancer volume 50, pages943–946 (2019).
  • Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al.
  • Submitted for Publication: Collusion: The façade and its implications on Total pain management in palliative care -IJPC_81_20 (Indian Journal of palliative care Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai.
  • Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141 patients, ICON 2009 Chennai.
  • Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid Leukemia – Chronic Phase treated with Imatinib mesylate AND possible correlation with electrolyte imbalances. Asia-Pacific Hematology consortium held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21.
  • A multicenter, open-label, single-arm, phase IV study of Trastuzumab Emtansine in Indian patients with HER2 positive unresectable locally advanced or metastatic breast cancer who have received prior treatment with trastuzumab and a taxane.
  • A multi-center, observational, data collection registry study to monitor the routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY INTAS PHARMACEUTICALS LTD) in Indian patients.
  • A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma.
  • Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient).
  • Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
  • Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018.
  • Co-Organizer of Best Of SABCS 2018 April 2018.
  • Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice (GCP) on 1st March 2019.
  • CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019.
  • Dr. Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA. Click Here
  • Dr. Peush Bajpai explains about how early diagnosis and detection can identify Breast Cancer symptoms and treat it successfully on TV9 Bharatvarsh (Digital) | FB Live Session. Click Here
  • Dr. Peush Bajpai in an authored article on Watch out, lumps are not the only symptom of breast cancer observing Breast Cancer Awareness Month in Times Now News. Click Here
  • Dr. Peush Bajpai in an exclusive story on Oncologist answers FAQs on the ideal routine for cancer treatment in Times Now| World Cancer Day. Click Here
  • Dr. Peush Bajpai on Cancer and Precision Medicine in a live webinar on Business World.Click Here
  • Dr. Peush Bajpai on Cancer Treatment: Can I Have Chemotherapy During Pregnancy? in The Healthsite (Zee Digital) | Exclusive story.Click Here
  • Dr. Peush Bajpai on Doctor Explains: Menace of cancer in India| The Financial Express | World Cancer Day. Click Here
  • Dr. Peush Bajpai said in an exclusive Story, "Nearly 50-60 per cent cancers are due to poor lifestyle" to Financial Express. Click Here
  • SM Post | NDTV. Click Here

Awards & Achievements

  • First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass.
  • First prize in the All India Quiz at the Lymphoma leukemia meet in Mumbai organized by the European Society of Medical Oncology.
  • Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances.

Languages Spoken

  • English
  • Hindi
  • Tamil

Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • ASCO
  • NCR oncology group
  • ISMPO
  • ICON
  • Dwarka IMA
  • SIOP

Field of Expertise

  • Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma
  • Gynaecological Malignancies - Carcinoma Ovary, the endometrium
  • Haematological Malignancies - Multiple Myeloma, CML, CLL, and Autologous Bone marrow transplant
  • Soft-tissue Sarcomas and Osteosarcoma
  • Thoracic Malignancies - Lung Carcinoma
  • Immunotherapy
  • Precision Oncology

Talks & Publications

  • Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck malignancy http://medej.tnmgrmu.ac.in 2 (2).
  • Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
  • Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al.
  • Novel formulations of docetaxel, paclitaxel, and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al.
  • Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce a Durable Response Peush Bajpai et al. Journal of Gastrointestinal Cancer volume 50, pages943–946 (2019).
  • Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al.
  • Submitted for Publication: Collusion: The façade and its implications on Total pain management in palliative care -IJPC_81_20 (Indian Journal of palliative care Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai.
  • Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141 patients, ICON 2009 Chennai.
  • Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid Leukemia – Chronic Phase treated with Imatinib mesylate AND possible correlation with electrolyte imbalances. Asia-Pacific Hematology consortium held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21.
  • A multicenter, open-label, single-arm, phase IV study of Trastuzumab Emtansine in Indian patients with HER2 positive unresectable locally advanced or metastatic breast cancer who have received prior treatment with trastuzumab and a taxane.
  • A multi-center, observational, data collection registry study to monitor the routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY INTAS PHARMACEUTICALS LTD) in Indian patients.
  • A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma.
  • Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient).
  • Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
  • Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018.
  • Co-Organizer of Best Of SABCS 2018 April 2018.
  • Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice (GCP) on 1st March 2019.
  • CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019.
  • Dr. Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA. Click Here
  • Dr. Peush Bajpai explains about how early diagnosis and detection can identify Breast Cancer symptoms and treat it successfully on TV9 Bharatvarsh (Digital) | FB Live Session. Click Here
  • Dr. Peush Bajpai in an authored article on Watch out, lumps are not the only symptom of breast cancer observing Breast Cancer Awareness Month in Times Now News. Click Here
  • Dr. Peush Bajpai in an exclusive story on Oncologist answers FAQs on the ideal routine for cancer treatment in Times Now| World Cancer Day. Click Here
  • Dr. Peush Bajpai on Cancer and Precision Medicine in a live webinar on Business World.Click Here
  • Dr. Peush Bajpai on Cancer Treatment: Can I Have Chemotherapy During Pregnancy? in The Healthsite (Zee Digital) | Exclusive story.Click Here
  • Dr. Peush Bajpai on Doctor Explains: Menace of cancer in India| The Financial Express | World Cancer Day. Click Here
  • Dr. Peush Bajpai said in an exclusive Story, "Nearly 50-60 per cent cancers are due to poor lifestyle" to Financial Express. Click Here
  • SM Post | NDTV. Click Here

Awards & Achievements

  • First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass.
  • First prize in the All India Quiz at the Lymphoma leukemia meet in Mumbai organized by the European Society of Medical Oncology.
  • Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances.

Talks & Publications

  • Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck malignancy http://medej.tnmgrmu.ac.in 2 (2).
  • Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
  • Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al.
  • Novel formulations of docetaxel, paclitaxel, and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al.
  • Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce a Durable Response Peush Bajpai et al. Journal of Gastrointestinal Cancer volume 50, pages943–946 (2019).
  • Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al.
  • Submitted for Publication: Collusion: The façade and its implications on Total pain management in palliative care -IJPC_81_20 (Indian Journal of palliative care Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai.
  • Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141 patients, ICON 2009 Chennai.
  • Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid Leukemia – Chronic Phase treated with Imatinib mesylate AND possible correlation with electrolyte imbalances. Asia-Pacific Hematology consortium held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21.
  • A multicenter, open-label, single-arm, phase IV study of Trastuzumab Emtansine in Indian patients with HER2 positive unresectable locally advanced or metastatic breast cancer who have received prior treatment with trastuzumab and a taxane.
  • A multi-center, observational, data collection registry study to monitor the routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY INTAS PHARMACEUTICALS LTD) in Indian patients.
  • A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma.
  • Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient).
  • Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
  • Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018.
  • Co-Organizer of Best Of SABCS 2018 April 2018.
  • Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice (GCP) on 1st March 2019.
  • CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019.
  • Dr. Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA. Click Here
  • Dr. Peush Bajpai explains about how early diagnosis and detection can identify Breast Cancer symptoms and treat it successfully on TV9 Bharatvarsh (Digital) | FB Live Session. Click Here
  • Dr. Peush Bajpai in an authored article on Watch out, lumps are not the only symptom of breast cancer observing Breast Cancer Awareness Month in Times Now News. Click Here
  • Dr. Peush Bajpai in an exclusive story on Oncologist answers FAQs on the ideal routine for cancer treatment in Times Now| World Cancer Day. Click Here
  • Dr. Peush Bajpai on Cancer and Precision Medicine in a live webinar on Business World.Click Here
  • Dr. Peush Bajpai on Cancer Treatment: Can I Have Chemotherapy During Pregnancy? in The Healthsite (Zee Digital) | Exclusive story.Click Here
  • Dr. Peush Bajpai on Doctor Explains: Menace of cancer in India| The Financial Express | World Cancer Day. Click Here
  • Dr. Peush Bajpai said in an exclusive Story, "Nearly 50-60 per cent cancers are due to poor lifestyle" to Financial Express. Click Here
  • SM Post | NDTV. Click Here

Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • ASCO
  • NCR oncology group
  • ISMPO
  • ICON
  • Dwarka IMA
  • SIOP

Field of Expertise

  • Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma
  • Gynaecological Malignancies - Carcinoma Ovary, the endometrium
  • Haematological Malignancies - Multiple Myeloma, CML, CLL, and Autologous Bone marrow transplant
  • Soft-tissue Sarcomas and Osteosarcoma
  • Thoracic Malignancies - Lung Carcinoma
  • Immunotherapy
  • Precision Oncology

Languages Spoken

  • English
  • Hindi
  • Tamil

Awards & Achievements

  • First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass.
  • First prize in the All India Quiz at the Lymphoma leukemia meet in Mumbai organized by the European Society of Medical Oncology.
  • Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances.

Awards & Achievements

  • First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass.
  • First prize in the All India Quiz at the Lymphoma leukemia meet in Mumbai organized by the European Society of Medical Oncology.
  • Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances.

Talks & Publications

  • Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck malignancy http://medej.tnmgrmu.ac.in 2 (2).
  • Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
  • Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al.
  • Novel formulations of docetaxel, paclitaxel, and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al.
  • Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce a Durable Response Peush Bajpai et al. Journal of Gastrointestinal Cancer volume 50, pages943–946 (2019).
  • Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al.
  • Submitted for Publication: Collusion: The façade and its implications on Total pain management in palliative care -IJPC_81_20 (Indian Journal of palliative care Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai.
  • Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141 patients, ICON 2009 Chennai.
  • Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid Leukemia – Chronic Phase treated with Imatinib mesylate AND possible correlation with electrolyte imbalances. Asia-Pacific Hematology consortium held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21.
  • A multicenter, open-label, single-arm, phase IV study of Trastuzumab Emtansine in Indian patients with HER2 positive unresectable locally advanced or metastatic breast cancer who have received prior treatment with trastuzumab and a taxane.
  • A multi-center, observational, data collection registry study to monitor the routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY INTAS PHARMACEUTICALS LTD) in Indian patients.
  • A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma.
  • Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient).
  • Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
  • Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018.
  • Co-Organizer of Best Of SABCS 2018 April 2018.
  • Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice (GCP) on 1st March 2019.
  • CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019.
  • Dr. Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA. Click Here
  • Dr. Peush Bajpai explains about how early diagnosis and detection can identify Breast Cancer symptoms and treat it successfully on TV9 Bharatvarsh (Digital) | FB Live Session. Click Here
  • Dr. Peush Bajpai in an authored article on Watch out, lumps are not the only symptom of breast cancer observing Breast Cancer Awareness Month in Times Now News. Click Here
  • Dr. Peush Bajpai in an exclusive story on Oncologist answers FAQs on the ideal routine for cancer treatment in Times Now| World Cancer Day. Click Here
  • Dr. Peush Bajpai on Cancer and Precision Medicine in a live webinar on Business World.Click Here
  • Dr. Peush Bajpai on Cancer Treatment: Can I Have Chemotherapy During Pregnancy? in The Healthsite (Zee Digital) | Exclusive story.Click Here
  • Dr. Peush Bajpai on Doctor Explains: Menace of cancer in India| The Financial Express | World Cancer Day. Click Here
  • Dr. Peush Bajpai said in an exclusive Story, "Nearly 50-60 per cent cancers are due to poor lifestyle" to Financial Express. Click Here
  • SM Post | NDTV. Click Here

Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • ASCO
  • NCR oncology group
  • ISMPO
  • ICON
  • Dwarka IMA
  • SIOP

Field of Expertise

  • Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma
  • Gynaecological Malignancies - Carcinoma Ovary, the endometrium
  • Haematological Malignancies - Multiple Myeloma, CML, CLL, and Autologous Bone marrow transplant
  • Soft-tissue Sarcomas and Osteosarcoma
  • Thoracic Malignancies - Lung Carcinoma
  • Immunotherapy
  • Precision Oncology

Languages Spoken

  • English
  • Hindi
  • Tamil